Post Malone looks a little different than he did when he first burst onto the music scene. Here’s what to know about the ...

What if the future of weight-loss drugs didn’t involve needles at all? Drugmakers are testing once-a-day pills and next-gen ...

The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...

The studies come as more and more women are turning to GLP-1 drugs to help them lose weight, particularly after menopause ...

Some people may be considering skipping a dose of their weight-loss medication so they can eat more on Thanksgiving, but ...

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...

The drug tested was Rybelsus, a pill approved only for type 2 diabetes. Like Novo's blockbusters Ozempic and Wegovy, it ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

Eli Lilly said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access ...

Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.

Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects. Brain scientists are looking for ways ...

Because these drugs have become particularly popular among women 50 to 64 years old, Mom and Nonna are helming the Great ...